UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 23 filers reported holding UROVANT SCIENCES LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,471,000 | -5.1% | 157,480 | 0.0% | 0.41% | -17.8% |
| Q2 2020 | $1,550,000 | +6.7% | 157,480 | 0.0% | 0.50% | -40.3% |
| Q1 2020 | $1,452,000 | -40.6% | 157,480 | 0.0% | 0.84% | -28.6% |
| Q4 2019 | $2,443,000 | +63.8% | 157,480 | 0.0% | 1.17% | +15.4% |
| Q3 2019 | $1,491,000 | +19.7% | 157,480 | 0.0% | 1.02% | +23.3% |
| Q2 2019 | $1,246,000 | -21.3% | 157,480 | 0.0% | 0.82% | -33.8% |
| Q1 2019 | $1,583,000 | +52.5% | 157,480 | 0.0% | 1.24% | +24.9% |
| Q4 2018 | $1,038,000 | – | 157,480 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|